Atom | Breakthrough T1D Request for Applications: Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies

Due Dates: May 28, 2025 (Letter of Intent) | July 16, 2025 (Full proposal)

Funding Amounts: Up to $600,000 total for up to 2 years (including 10% indirect costs); typical award duration is 2 years.

Summary: Supports development of innovative technologies to enable large-scale manufacturing and deployment of islet cell therapies for type 1 diabetes.

Key Information: LOI required; open to academic and industry investigators worldwide.

Breakthrough T1D Request for Applications: Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies

Sign in to see full grant listing